Biohaven

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biohaven and other ETFs, options, and stocks.

About BHVN

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

CEO

Vladimir Coric

CEOVladimir Coric

Employees

239

Employees239

Headquarters

New Haven, Connecticut

HeadquartersNew Haven, Connecticut

Founded

2022

Founded2022

Employees

239

Employees239

BHVN Key Statistics

Market cap

3.49B

Market cap3.49B

Price-Earnings ratio

-7.09

Price-Earnings ratio-7.09

Dividend yield

—

Dividend yield—

Average volume

1.80M

Average volume1.80M

High today

$41.50

High today$41.50

Low today

$39.29

Low today$39.29

Open price

$40.52

Open price$40.52

Volume

797.62K

Volume797.62K

52 Week high

$62.21

52 Week high$62.21

52 Week low

$12.96

52 Week low$12.96

Analyst ratings

100%

of 11 ratings

Buy

100%

Hold

Sell

Biohaven

Why Robinhood?

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT. Show more

BHVN Key Statistics

Analyst ratings

100%

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.